Articles Archives - Page 287 of 715

MondayMar 07, 2022 11:30 am

SPYR Inc. (SPYR) Featured in Emerging Markets Report, Expands Airing Schedule of Its MagixDrive Commercial

SPYR was featured in a recent report highlighting the company’s intention to stake its claim in the burgeoning global Internet of Things market The company continues to identify and target acquisitions to potentially grow its footprint in the industry and increase its product offerings, the report notes SPYR also announced it had further expanded the airing schedule of its MagixDrive national commercial to help more customers discover the wireless CarPlay device SPYR (OTCQB: SPYR), dba SPYR Technologies, was featured in a recent Emerging Markets Report published by investor relations consultants Emerging Markets Consulting (“EMC”). Entitled “Home Smart Home.” The report…

MondayMar 07, 2022 11:15 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gives Corporate Presentation, Q&A Session at Virtual Investor 2022 Top Picks Conference

The company also participated in the H.C. Wainwright BioConnect Conference earlier in January CNS Pharmaceuticals recently received approval from swissethics for a pivotal Berubicin and GBM clinical trial The five-year survival rate for GBM is only 6.8%, with the average patient population surviving 12 to 18 months after diagnosis CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently participated in the Virtual Investor 2022 Top Picks Conference. During the event, CEO John Climaco provided a corporate presentation and then participated in a…

MondayMar 07, 2022 11:15 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Is ‘One to Watch’

EverGen forecasts EBITDA growth from about C$3 million in 2021 to more than C$12 million in the next 12 months from expansion of core operating assets EverGen stock began trading in the U.S. on the OTCQB Venture Market under ticker symbol ‘EVGIF’ on February 15, 2022 EverGen has low-risk long term contracted or reoccurring revenue (similar to Large Cap Independent Power Producers), with two revenue sources via RNG sales and organic waste tip-fee contracts providing a high margin business with EBITDA margins of 50-60% In its most recent reporting, the company reported gross profit of C$1.58 million on revenue of…

MondayMar 07, 2022 11:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Chopra Foundation Partner in Efforts to Support Progress Toward Psychedelic-Based Therapeutics

Psychedelic drugs are on cusp of entering mainstream treatment for mental illness Cybin, Chopra Foundation to collaborate on efforts aimed to support education, awareness about psychedelic therapy mental health research Cybin “one of the only companies that may truly address the needs of patients and providers,” says Dr. Deepak Chopra A significant increase in research and growing public support are key indicators of the future of psychedelics, which are “on the cusp of entering mainstream psychiatry,” according to a recent “New York Times” article (https://ibn.fm/GshwS). Another strong indicator of the future of psychedelics is the exciting partnership just announced by…

MondayMar 07, 2022 11:00 am

Cepton Inc.’s (NASDAQ: CPTN) Management Rings Nasdaq Opening Bell After Commencing Formal Trade on the Exchange

Cepton, Inc formally listed on the Nasdaq Capital Market on February 11, 2022, following the merger between Cepton Technologies Inc., and SPAC, Growth Capital Acquisition Corp (GCAC) Cepton’s CEO, Dr. Jun Pei rang the Nasdaq opening bell on Thursday, February 17, alongside CTO Dr. Mark McCord and members of both, Cepton Technologies and Growth Capital Acquisition Corp GCAC and Cepton arrived at a formal combination agreement on August 5, 2021, with the transaction valuing Cepton at an enterprise value of $1.5 billion Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMR(R) lidar solutions, held the opening bell…

FridayMar 04, 2022 9:30 am

Investor Summit Q1 Conference – featuring C Level Management of 65 + Companies

Companies and investors are invited to attend the Q1 2022 Virtual Investor Summit being held as a virtual event on March 8-9th, 2022. The Investor Summit has been the largest independent conference on the East Coast for many years (formerly "The Microcap Conference") and represents companies that are looking for a timely platform to connect with investors. The Q1 investor Summit focuses on connecting small and microcap companies with potential investors from large institutions, family businesses, private wealth and money managers. This Q1 conference will offer C level executives the opportunity to make presentations about the state of their business,…

FridayMar 04, 2022 9:30 am

34th Annual ROTH Conference To Be Held As An In-person Event In California

The Roth Capital Partners invites small-cap companies, entrepreneurs, industries, and businesses to attend the 34th Annual ROTH Conference being held on March 13-15, 2022 at The Ritz Carlton, Laguna Niguel, Dana Point, California. Respected heads and leaders of leading companies from a spectrum of diverse sectors, including consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, technology, and more, will be gracing the occasion. Roth is a privately-owned investment banking firm dedicated to offering growth and networking opportunities to the small-cap public market. With previous years showing some exciting feedback and responses from participants, sponsors and presenting companies, Roth Conferences are now…

FridayMar 04, 2022 9:15 am

SRAX Inc. (NASDAQ: SRAX) Foresee Surging Revenue as Millennials are All-In on Corporate Transparency

SaaS company SRAX offers a robust suite of cutting-edge products that facilitate engagement between public companies and investors, both existing and potential SRAX forecasts a record first quarter of $11.5 million in revenue as part of 2022 revenue in the range of $46-$48 million The company bought back ~$800,000 during Q2 2021, paid a dividend in January, and optimized its cap table via the elimination of an ATM filing There are common fundamental threads between investing 30 years ago and today, but many things are extremely different. The digital age has changed everything, and fintech companies like SRAX (NASDAQ: SRAX)…

FridayMar 04, 2022 9:15 am

Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective use The company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating high blood pressure and heart disease, nicotine addiction, and virus infection Most recently, the company reported successes in increasing the speed and effectiveness in a drug treating erectile dysfunction (“ED”) in laboratory animals Lexaria is preparing an investigational new drug (“IND”) application for its hypertension line of study with the aim of achieving a new drug application (“NDA”) approval from…

FridayMar 04, 2022 9:00 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Adds Indonesia Node as Lightning Network Reaches All-Time High

Bitcoin locked on the Lightning Network has an estimated value of US$1.3 billion – indicating a bullish market contrary to the Bitcoin bear market LQwD has nodes active on the Lightning Network in the U.S., Germany, Singapore, and Indonesia, growing at an exponential rate by the day The Bitcoin Payment Ecosystem is expected to reach US$880 million by 2026 LQwD launched its PaaS offering in November, aiming to facilitate payments worldwide Bitcoin reached an all-time high of US$61,374.28 in October 2021, but since then the cryptocurrency’s value fluctuated significantly, dropping to US$37,928.58 in January 2022 (https://ibn.fm/OMawU). Throughout February, Bitcoin value…

Site Search

Company Search

Category: Articles